Publication | Open Access
A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer
26
Citations
33
References
2021
Year
We developed the MRSB, an eight-gene-based methylation signature, which has great potential to be used to predict the post-surgery progression risk of BLCA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1